Registered entities
Ra Pharmaceuticals, Inc.
Reg. No. 1481512United States
Innovation
23 patent families (13 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 7,361 times.
| Year | Filings |
|---|---|
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 11 |
| 2020 | 13 |
| 2021 | 16 |
| 2022 | 16 |
| 2023 | 11 |
| 2024 | 9 |
| 2025 | 7 |
| 2026 | 1 |
Investor mix
9 investors on record; lead investors include RA Capital Management, New Enterprise Associates, Morgenthaler, Lightstone Ventures; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 56% |
| Private equity | 1 | 11% |
| Other / undisclosed | 3 | 33% |